Physician profile
Gaurav Kumar
NPI 1598796369
$7,552.74
in general payments reported to CMS, 2019-2025
16 companies · $607 in 2025
The $607 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $118 · 2021: $510 · 2022: $726 · 2023: $2,093 · 2024: $3,153 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,372 · Travel and Lodging: $2,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,372.14 |
| Travel and Lodging | $2,480.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,818.19 | 2021-2024 | Indigo System |
| Abiomed | $810.17 | 2022-2025 | Impella |
| Abbott Laboratories | $662.89 | 2019-2025 | Esprit, Optis |
| Boston Scientific Corporation | $448.64 | 2019-2023 | Ranger |
| Edwards Lifesciences Corporation | $315.52 | 2019-2023 | Inspiris Resilia Aortic Valve |
| Philips North America LLC | $230.47 | 2022-2023 | |
| Biotronik INC. | $227.68 | 2022 | |
| Inari Medical, INC. | $179.03 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $147.29 | 2024 | Corevalve Evolut R |
| Stryker Corporation | $138.72 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $123.77 | 2021 | |
| Asahi Intecc USA, INC. | $117.55 | 2020 | |
| Amgen INC. | $116.17 | 2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.95 | 2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.55 | 2023 | Lifevest |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $22.15 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gaurav Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.